These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15722060)

  • 1. Phenidone, a dual inhibitor of cyclooxygenases and lipoxygenases, ameliorates rat paralysis in experimental autoimmune encephalomyelitis by suppressing its target enzymes.
    Moon C; Ahn M; Wie MB; Kim HM; Koh CS; Hong SC; Kim MD; Tanuma N; Matsumoto Y; Shin T
    Brain Res; 2005 Feb; 1035(2):206-10. PubMed ID: 15722060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU).
    Bora NS; Sohn JH; Bora PS; Kaplan HJ; Kulkarni P
    Ocul Immunol Inflamm; 2005; 13(2-3):183-9. PubMed ID: 16019677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
    Alvaro-Gracia JM
    Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i21-5. PubMed ID: 14752172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
    Kong W; Hooper KM; Ganea D
    Brain Behav Immun; 2016 Mar; 53():59-71. PubMed ID: 26541818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Jan; 60(1):7-13. PubMed ID: 15652362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors.
    de Gaetano G; Donati MB; Cerletti C
    Trends Pharmacol Sci; 2003 May; 24(5):245-52. PubMed ID: 12767724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclooxygenases.
    Moon C; Ahn M; Jee Y; Heo S; Kim S; Kim H; Sim KB; Koh CS; Shin YG; Shin T
    Neurosci Lett; 2004 Feb; 356(2):123-6. PubMed ID: 14746879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1.
    Kang JC; Ahn M; Kim YS; Moon C; Lee Y; Wie MB; Lee YJ; Shin T
    J Vet Sci; 2001 Aug; 2(2):85-9. PubMed ID: 14614276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity.
    Li Z; Choi DY; Shin EJ; Hunter RL; Jin CH; Wie MB; Kim MS; Park SJ; Bing G; Kim HC
    Neurosci Lett; 2008 Nov; 445(1):1-6. PubMed ID: 18760329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.
    Simmons RD; Hugh AR; Willenborg DO; Cowden WB
    Acta Neurol Scand; 1992 Mar; 85(3):197-9. PubMed ID: 1575003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
    Gay RE; Neidhart M; Pataky F; Tries S; Laufer S; Gay S
    J Rheumatol; 2001 Sep; 28(9):2060-5. PubMed ID: 11550975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
    Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
    Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib.
    Li N; Sood S; Wang S; Fang M; Wang P; Sun Z; Yang CS; Chen X
    Clin Cancer Res; 2005 Mar; 11(5):2089-96. PubMed ID: 15756036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
    Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
    Vidal C; Gómez-Hernández A; Sánchez-Galán E; González A; Ortega L; Gómez-Gerique JA; Tuñón J; Egido J
    J Pharmacol Exp Ther; 2007 Jan; 320(1):108-16. PubMed ID: 17015640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.